Castor vs the COVID-19 virus

Castor announced continued support for the WHO Solidarity trial, the world’s largest adaptive COVID-19 trial.

Watch this webinar for tips on how to ensure research continuity during COVID-19 by running your trial with a more decentralized approach.

Watch this webinar for tips on how to ensure research continuity during COVID-19 by running your trial with…

The following is an excerpt from our free whitepaper ‘Satisfying PMCF requirements by utilizing IIS data’. Click here…

Join this webinar to understand how eConsent works, where it falls in the regulatory guidelines & see a practical demonstration of eConsent software.

Hoboken, New Jersey: September 2, 2020: Castor, a leading provider of clinical trial technology that automates the research…

With 4,000 live studies and 2M enrolled patients across 90 countries, Castor will use the funding to further…

The world may have changed seemingly overnight, but clinical research and medical innovation must continue now more than…

When the COVID-19 pandemic began, the industry needed to focus immediately on research continuity and determine how to mitigate the impact on clinical trials while protecting participant safety.

Download this white paper to learn why patient-centric, remote research technologies such as eConsent, EDC, and ePRO are critical during COVID-19 and beyond.